Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #34104 on Ariad Pharmaceuticals Inc fka ARIA
rurik
09/12/13 2:10 PM
#34107 RE: jaybe #34104
iandy
09/12/13 2:31 PM
#34108 RE: jaybe #34104
In March 2011, TESARO signed an agreement with Amgen Inc. for exclusive worldwide rights for the development, manufacture, commercialization and distribution of small molecule inhibitors of Anaplastic Lymphoma Kinase (ALK), including TSR-011. The agreement included an upfront payment and potential future payments and royalties associated with the achievement of certain development and commercial milestones.